Tempus

Tempus connects lab-grade genomic sequencing with structured clinical data to create a high-resolution view of each patient’s health. Using AI, Tempus aids doctors in identifying targeted therapies, uncovering clinical trials, and improving treatment decisions. It serves life sciences companies, academic centers, and hospital networks.

Key Features:

• Genomic Profiling – Targeted DNA & RNA sequencing for tumor and hereditary testing.
• Real-World Data Library – Access to one of the largest de-identified datasets in healthcare.
• Tempus One – AI-powered clinical decision support for physicians.
• CLIA-Certified Lab Testing – CAP-accredited lab for rapid and compliant results.
• xT Platform – 648+ gene panel for actionable tumor profiling.
• Clinical Trial Matching – Real-time matching to recruiting trials based on molecular profile.
• Mobile & Web Dashboard – Patient-specific reports and decision tools at your fingertips.
• AI & Machine Learning Models – Predictive modeling for patient outcomes and risk.

Pricing :

Tempus does not disclose pricing publicly. Costs may vary based on test type (e.g., xT, xG, xF) and institutional agreement. Coverage is available through Medicare, Medicaid, and most private insurers.